abagovomab 19
abciximab 21
abituzumab 19
abrilumab 13
actoxumab 8
adalimumab 15
aducanumab 8
afasevikumab 11
alacizumab_pegol 8
alemtuzumab 20
alirocumab 10
amatuximab 26
andecaliximab 15
anifrolumab 13
anrukinzumab 16
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 13
ascrinvacumab 4
atezolizumab 13
atinumab 12
avelumab 8
basiliximab 16
bavituximab 19
begelomab 13
benralizumab 17
bevacizumab_beta 17
bezlotoxumab 8
bimagrumab 9
bleselumab 9
blinatumomab 21
blosozumab 26
bococizumab 14
brazikumab 14
brentuximab_vedotin 15
briakinumab 15
brodalumab 6
brolucizumab 22
brontictuzumab 17
burosumab 14
cabiralizumab 19
camrelizumab 9
canakinumab 19
cantuzumab_ravtansin 30
carlumab 12
carotuximab 12
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 23
cetiximab 30
citatuzumab_bogatox 24
cixutumumab 14
clivatuzumab_tetraxetan 14
codrituzumab 21
conatumumab 9
concizumab 17
crenezumab 14
crizanlizumab 19
crotedumab 18
dacetuzumab 21
daclizumab 10
dalotuzumab 24
dapirolizumab_pegol 19
daratumumab 12
dectrekumab 8
demcizumab 18
denosumab 8
depatuxizumab 15
depatuxizumab_mafodotin 15
dezamizumab 11
dinutuximab 29
diridavumab 10
domagrozumab 12
drozitumab 5
duligotuzumab 14
durvalumab 4
dusigitumab 7
efalizumab 27
efungumab 17
eldelumab 11
elezanumab 11
elgemtumab 9
elotuzumab 9
emactuzumab 14
emapalumab 21
emibetuzumab 13
enavatuzumab 22
enfortumab_vedotin 10
enoblituzumab 14
enokizumab 18
enoticumab 15
ensituximab 16
eptinezumab 11
erenumab 12
etaracizumab 14
etrolizumab 22
evinacumab 16
evolocumab 7
farletuzumab 3
fasinumab 16
fezakinumab 7
fibatuzumab 6
ficlatuzumab 13
firivumab 23
flanvotumab 10
fletikumab 14
foralumab 9
foravirumab 12
fremanezumab 24
fresolimumab 16
fulranumab 18
futuximab 17
galcanezumab 8
ganitumab 18
gantenerumab 7
gemetuzumab 19
gemtuzumab2 18
gemtuzumab 16
gevokizumab 20
girentuximab 20
glembatumumab 14
glembatumumab_vedotin 14
guselkumab 16
ibalizumab 21
ibritumomab 13
icrucumab 7
idarucizumab 19
ifabotuzumab 6
imalumab 14
imgatuzumab 14
inclacumab 15
indatuximab_ravtansin 18
indusatumab 10
inebilizumab 19
intetumumab 6
iodine_girentuximab 27
ipilimumab 0
iratumumab 4
isatuximab 16
itolizumab 19
ixekizumab 22
labetuzumab_govitecan 14
lambrolizumab 20
lampalizumab 17
lanadelumab 17
landogrozumab 12
laprituximab 20
lebrikizumab 23
lendalizumab 21
lenzilumab 11
lifastuzumab_vedotin 24
ligelizumab 19
lilotomab 21
lirilumab 18
lodelcizumab 15
lokivetmab 16
lorvotuzumab_mertansin 12
lucatumumab 26
lumretuzumab 12
lupartumab 10
lutikizumab 15
margetuximab 27
milatuzumab 25
mirvetuximab 21
mirvetuximab_soravtansin 21
modotuximab 28
mogamulizumab 22
monalizumab 16
motavizumab 22
moxetumomab_pasudotox 19
namilumab 13
naratuximab 17
naratuximab_emtansin 17
narnatumab 13
navicixizumab2 20
navicixizumab 20
navivumab 24
necitumumab 7
nemolizumab 18
nesvacumab 11
nivolumab 11
obiltoxaximab 16
obinutuzumab 28
ocaratuzumab 15
ofatumumab 13
olaratumab 14
olokizumab 23
omalizumab 17
onartuzumab 19
ontuxizumab 15
opicinumab 13
orticumab 10
otelixizumab 32
oxelumab 8
ozanezumab 19
pamrevlumab 8
panobacumab 15
parsatuzumab 24
pasotuxizumab 17
pateclizumab 12
patritumab 10
pembrolizumab 20
perakizumab 21
pidilizumab 12
pinatuzumab_vedotin 13
plozalizumab 21
pogalizumab 17
polatuzumab_vedotin 16
ponezumab 23
prezalumab 10
pritoxaximab 19
quilizumab 17
racotumomab 21
radretumab 13
ralpancizumab 19
ramucirumab 11
ranevetmab 23
ranibizumab 17
refanezumab 18
remtolumab 16
rilotumumab 12
rinucumab 13
risankizumab 29
rituximab 13
rivabazumab 13
robatumumab 20
roledumab 17
romosozumab 17
rontalizumab 15
rosmantuzumab 19
rozanolixizumab 17
sacituzumab 18
sacituzumab_govitecan 18
samalizumab 16
sapelizumab 20
sarilumab 15
secukinumab 9
seribantumab 15
setoxaximab 29
sifalimumab 3
siltuximab 17
simtuzumab 18
sirukumab 9
solanezumab 24
solitomab 14
stamulumab 14
suptavumab 19
suvizumab 9
tabalumab 9
tadocizumab 9
tamtuvetmab 25
tanezumab 17
tarextumab 8
tavolixizumab 11
telisotuzumab 18
teplizumab 11
tesidolumab 13
tezepelumab 19
tigatuzumab 14
tildrakizumab 14
timolumab 11
tisotumab 8
tosatoxumab 21
tositumomab 13
tralokinumab 21
trastuzumab 19
tregalizumab 20
trevogrumab 11
ublituximab 13
urelumab 12
ustekinumab 22
utomilumab 19
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 14
vantictumab 12
vanucizumab2 17
vanucizumab 22
varlilumab 12
vatelizumab 17
vedolizumab 12
veltuzumab 4
vesencumab 9
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 25
xentuzumab 14
zatuximab 28
